- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06508723
Comparison of Dental Implants with Different Surface Properties
Long-term Clinical and Radiographic Comparison of Dental Implants with Different Surface Properties Placed in the Posterior Region
This controlled, parallel clinical study aims to compare the effect of fixed prosthetic restorations placed in the posterior region with different implant surfaces on clinical and peri-implant marginal bone loss.
The main question(s) it aims to answer are:
Is there a difference between peri-implant marginal bone loss levels in dental implants with two different surfaces placed in the posterior region? Is there a difference in peri-implant clinical parameters in dental implants with two different surfaces placed in the posterior region? The study includes a test group (implant with Ti-Ulta surface) and a control group (implant with Ti-Unite surface).
Two implants with different surfaces will be placed in the bone following the same routine implant placement protocol.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dental implants have become one of the most common treatments used for the rehabilitation of lost teeth. Dental implant surfaces have been roughened in different ways to increase the degree of osseointegration. A recent review reported that five different types of implant surfaces have been documented over more than 10 years. These surfaces were evaluated in 5 parts: machined, titanium plasma spray (TPS), sprayed, SLA (sandblasted and acid-etched), and anodized. The properties of an implant surface have long been identified as an essential factor in achieving and maintaining osseointegration. Modifications made to the implant body surface aim to support osseointegration and the reduction of bacterial adhesion. Pathogenic microbial colonization can lead to peri-implantitis and peri-implant marginal bone loss, resulting in dental implant failure. Roughness, porosity, and surface chemistry are essential factors for osseointegration. In particular, surface chemistry is vital in increasing cell adhesion.
An example of those produced by rearrangement of the outermost surface layer is the Ti-Unite (Nobel Biocare AG, Zurich, Switzerland) implant, where the oxide thickness is increased, and an anodizing process breaks the boundary between titanium crystals. Ti-Unite was introduced in 2001 and is among the best-selling dental implant surfaces worldwide. Nowadays, the Ti-Ultra (Nobel Biocare AG, Zurich, Switzerland) surface structure is being introduced. This redesigns the surface chemistry and topography to optimize tissue integration at all implant levels. Ti-Ultra is an ultra-hydrophilic, multizone, anodized implant surface with a graduated surface from implant neck to apex. There are studies in the literature comparing different implant surfaces.
The aim of this study is to compare the effects of fixed prosthetic restorations placed in the posterior region with different implant surfaces on clinical and peri-implant marginal bone loss.
The study will be carried out by Kütahya Health Sciences University, Faculty of Dentistry, Department of Periodontology. Systemically healthy patients between the ages of 18 and 99 and patients who have missing teeth in the posterior region and want to have a restoration with a dental implant will be included. Patients will be evaluated in two different groups: test and control groups. Patients were assigned to study groups. It will be distributed randomly and with a sealed envelope method. While dental implants with a Ti-Ultra surface will be included in the test group, dental implants with a Ti-Unite surface will be placed in the control group. All patients will undergo implant surgery and prosthetic restorations with the protocol recommended by the same company. After functional loading, patients will be followed for 12 months and routine clinical evaluations will be performed. Measurements and radiographic examinations will be obtained.
Before the operation, systemic and dental anamnesis will be taken from the patients and clinical measurements will be recorded. Periodontal indices such as plaque index, gingival index, bleeding on probing index and pocket depth will be recorded in both implant groups. Before the operation, the patient's bone amount will be evaluated on cone beam computed tomography and planning will be made. In both implant groups, keratinized mucosal thickness, keratinized mucosal height and vertical mucosal height will be measured in the area where the implant will be placed. Before and during the dental implant treatment operation, mesial, distal, buccal and lingual-palatal bone thickness measurements of the implant socket will be made with a digital caliper. Post-operative (T0), post-prosthetic loading (T1), 6th month (T2) and 1st year (T3) periapical x-rays will be taken. The amount of peri-implant marginal bone loss will be evaluated using software on standardized control periapical radiographs to be taken at the end of one-year follow-up.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kütahya, Turkey, 43100
- Kütahya Health Sciences University Faculty of Dentistry, Department of Periodontology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Please find below the revised text which is clearer and free of any spelling, grammar or punctuation errors:
- The patient must be between the ages of 18 to 99 years.
- The patient should not have any systemic diseases.
- There must be a toothless area in either the mandibular or maxillary region.
- There must be natural teeth present in the opposing arch.
- The patient should be periodontally healthy.
- There should not be any oral or mucosal diseases present.
- There must be sufficient bone present for implant placement, with a diameter of at least 3.5 mm and a height of 8 mm.
Exclusion Criteria:
Please find below a list of factors that may affect dental treatment and require special consideration:
- Patients who fall outside the specified age range.
- Patients with systemic diseases.
- Patients who have received radiotherapy to the head and neck region.
- Patients who have bruxism habits.
- Patients who smoke more than 10 cigarettes per day.
- Patients who use drugs that suppress the immune system or impair healing, such as steroids or bisphosphonates.
- Patients with alcohol and substance addiction.
- Patients who do not comply with treatment.
- Pregnant women and those who are breastfeeding.
- Mentally retarded patients.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Test Group
The group in which implants with a Ti-Ultra surface are placed.
|
The same routine implant placement protocol will be applied to both study groups with different surfaces and will be placed in the bone.
After local anesthesia, a full-thickness flap will be raised.
The implant socket will be created according to the protocol recommended by the company and all implants will be placed in the socket with a torque force of 35 N and the implants will be placed.
Once bleeding control is achieved, the flap will be closed primarily.
Healing caps will be installed after 3 months.
After waiting for wound healing, prosthetic restoration will be performed.
|
|
Other: Control Group
The group in which implants with a Ti-Unite surface are placed.
|
The same routine implant placement protocol will be applied to both study groups with different surfaces and will be placed in the bone.
After local anesthesia, a full-thickness flap will be raised.
The implant socket will be created according to the protocol recommended by the company and all implants will be placed in the socket with a torque force of 35 N and the implants will be placed.
Once bleeding control is achieved, the flap will be closed primarily.
Healing caps will be installed after 3 months.
After waiting for wound healing, prosthetic restoration will be performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peri-implant marginal bone loss
Time Frame: 1-year follow-up of all implants after prosthetic loading
|
The primary outcome was the assessment of marginal bone loss on radiographs at 1-year follow-up.
|
1-year follow-up of all implants after prosthetic loading
|
Collaborators and Investigators
Investigators
- Principal Investigator: Berceste Guler Ayyildiz, Kutahya Health Science University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-03/04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-Implantitis
-
University of ManitobaUnknownPeri ImplantitisCanada
-
Istanbul Medipol University HospitalAnkara University; Ankara Medipol University; Lokman Hekim UniversityCompletedPeri Implantitis | Peri-Implant Health | Peri Implant MucositisTurkey (Türkiye)
-
King Abdullah University HospitalJordan University of Science and TechnologyCompletedPeri-Implantitis and Peri-implant MucositisJordan
-
University of PittsburghRecruiting
-
Research Centre for Medical Genetics, Russian FederationCompleted
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
Rambam Health Care CampusCompletedDental Implants,Peri-implantitis,SmokingIsrael
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
Recep Tayyip Erdogan UniversityNot yet recruitingPeri Implantitis | Peri Implant Mucositis
Clinical Trials on Dental implant placement
-
Gulf Medical UniversityNot yet recruitingTooth Loss | Peri-implant Bone Loss | EdentulismUnited Arab Emirates
-
Hospital General Universitario Morales MeseguerNot yet recruiting
-
Kahramanmaras Sutcu Imam UniversityCompletedDental Implants | Cold Atmospheric PlasmaTurkey (Türkiye)
-
Università Vita-Salute San RaffaeleCompleted
-
Aula Dental AvanzadaActive, not recruiting
-
Aula Dental AvanzadaMozo Grau TicareRecruitingBone Resorption | Dental ImplantSpain
-
PerioCentrum ResearchUnknownImplant Geometry, Osseointegration, Soft Tissue Volume, Marginal Bone Levels, Soft Tissue Recession, Volumetric AnalysisSpain
-
UConn HealthDentsply Astra techCompletedImplant Survival Using Immediate Loading ProtocolUnited States
-
Krishnadevaraya College of Dental Sciences & HospitalCompleted
-
Assistance Publique - Hôpitaux de ParisRecruitingX-linked HypophosphatemiaFrance